T4	Exp 125 127	it
T5	Exp 269 271	it
T6	Exp 207 211	When
T7	Exp 265 268	how
T8	Exp 333 335	it
T9	Exp 352 363	the benefit
T10	Exp 442 458	the cell surface
T11	Exp 486 510	the activated macrophage
T12	Exp 512 516	When
T13	Exp 888 893	which
T14	Exp 659 684	The disappointing results
T15	Exp 732 746	the prediction
T16	Exp 798 810	the validity
T17	Exp 838 851	the soundness
T18	Exp 865 884	the clinical trials
T19	Exp 814 826	those models
T20	Exp 1067 1092	their murine counterparts
T21	Exp 1002 1006	that
T22	Exp 923 938	The variability
T23	Exp 959 992	the most narrowly targeted agents
T24	Exp 1007 1021	these diseases
T25	Exp 1179 1181	it
T26	Exp 1226 1235	the basis
T27	Exp 1264 1274	the moment
T28	Exp 1285 1294	the field
T29	Exp 1443 1458	the definitions
T30	Exp 1506 1524	the biologic level
T31	Exp 1607 1612	which
T32	Exp 1651 1656	which
T33	Exp 1691 1708	the armamentarium
R5	Coref Anaphora:T5 Antecedent:T34
R6	Coref Anaphora:T8 Antecedent:T34
R7	Coref Anaphora:T13 Antecedent:T18
R8	Coref Anaphora:T20 Antecedent:T24
T1	Protein 415 424	TNF-alpha
T2	Protein 709 714	IL-10
T3	Protein 906 911	IL-10
T34	Exp 212 221	a therapy
